Quality Risk Management for Biopharmaceuticals

Description

Quality Risk Management (QRM) has evolved from a compliance requirement to a strategic imperative that fundamentally shapes biopharmaceutical manufacturing excellence. This comprehensive white paper covers the 2023 revision of ICH Q9 (R1), addressing critical gaps in objectivity, formality, and risk-based decision-making while emphasizing product availability and digital transformation. Learn how to implement robust QRM systems integrating artificial intelligence, machine learning, and advanced analytics into risk management processes. Perfect for experienced quality professionals seeking to understand modern quality risk management frameworks, regulatory expectations, and proven industry practices.